Andreas Marzinzik und Biomedical Research - Info zur Person

(1 - 5 von 6

)

ABL001, a Potent Allosteric Inhibitor of BCR-ABL, Prevents Emergence...

ashpublications.org

Andreas Marzinzik,. Andreas Marzinzik *. 1Novartis Institutes for Biomedical Research, Inc, Cambridge, MA. Search for other works by this ...

1888 PressRelease.com - Latest Press Releases - Free Press Release...

rss2.com

Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a ...

Pardon Our Interruption

www.drugdiscoverychemistry.com

Andreas Marzinzik, Ph.D., Director, Lead Generation Chemistry, Novartis Institutes for BioMedical Research. ABL001 is a potent, selective BCR-ABL inhibitor ...

Going Beyond the Bone :: ChemViews Magazine ...www.chemistryviews.org › ezine

www.chemistryviews.org

... at the Novartis Institutes for Biomedical Research led by Wolfgang Jahnke and Andreas Marzinzik, discovered new FPPS inhibitors.

Library Design for Fragment Based Screening | Bentham Science

www.eurekaselect.com

Author(s): Ansgar Schuffenhauer, Simon Ruedisser, Andreas Marzinzik, Wolfgang Jahnke, Paul Selzer, Edgar Jacoby. Novartis Institutes ofBiomedical Research ...

Alle Infos zum Namen "Andreas Marzinzik"

Verwandte Suchanfragen zu Andreas Marzinzik

Kirk Wright
Martin Geiser
Clemens Scheufler

Johannes Ottl
Kristina Burow
Claus Ehrhardt

Nils Ostermann

Personen
Vorname "Andreas" (97752)
Name "Marzinzik" (71)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z